Exon 5 was replaced with a modified one in which nucleotide substitutions (GA-to-CG) result in the amino acid substitution of glutamic acid with arginine at position 177 (p.E177R), mimicking a mutation found in some human tumors. A loxP site flanked puromycin resistance gene cassette was inserted into intron 1. Authors state that this is a null allele.